Ozempicpancreatitistreatment The emergence of semaglutide (marketed as Ozempic and Wegovy) has offered a significant advancement in managing type 2 diabetes and obesity.Semaglutide-Induced Acute Pancreatitis Leading to Death ... However, like many medications, it carries potential side effects, and a key concern that has emerged is the relationship between semaglutide and pancreatitis. This article aims to explore this complex issue, drawing on current research and clinical understanding to provide a comprehensive overview.作者:W Masson·2024·被引用次数:29—This updated meta-analysis demonstrates that the use ofsemaglutide is not associated with an increased risk of acute pancreatitiscompared to placebo.
While the widespread use of semaglutide has led to increased reports of various adverse events, including acute pancreatitis, the scientific community is actively investigating the exact nature of this association作者:M Sodhi·2023·被引用次数:475—Studies have foundincreased risks of gastrointestinal adverse events(biliary disease, pancreatitis, bowel obstruction, and gastroparesis) in .... Some studies suggest that semaglutide treatment and the risk of acute pancreatitis may not be as high as initially feared. For instance, a meta-analysis by Masson et al. (2024) demonstrated that the use of semaglutide is not associated with an increased risk of acute pancreatitis compared to placebo. Similarly, the SUSTAIN-6 trial, as highlighted by Borra et alGLP-1 receptor agonists and dual GLP-1/GIP .... (2024), found no significant difference in the development of acute pancreatitis in patients on semaglutide versus placebo. This has led some experts to conclude that semaglutide is safe for most people in this regardFATAL CASE OF SEVERE ACUTE NECROTIZING ... - Chest.
However, it is crucial to acknowledge that most case reports indicate acute pancreatitis as a side effect that can occur shortly after semaglutide exposure2025年5月19日—Althoughsemaglutide is safe for most people, it's important to know about potential side effects. One rare but serious risk is pancreatitis, .... There are documented instances and case studies, such as those presented by Dagher et al. (2024) and Altaweel et al. (2024), which detail semaglutide-induced pancreatitis.Clinicians avoid using GLP-1s in patients with a history of acutepancreatitis, but recent meta-analyses do not support a class-wide risk. The mechanism proposed for this potential link involves the direct stimulation of GLP-1 receptors increatic cells by semaglutide, which may theoretically lead to cell overgrowth and changes in pancreatic function. Furthermore, specific severe outcomes, including semaglutide induced necrotizing pancreatitis and even fatalities, have been reported in rare instances, emphasizing the need for vigilance. Geertz et al. (2025) also noted that while semaglutide is known for gastrointestinal side effects, pancreatitis is considered rare.作者:F Patel·2023·被引用次数:27—Though recent evidence suggestsno increased risk of acute pancreatitis(AP) with subcutaneous semaglutide use, some studies report an increase in pancreatic ...
It's important to differentiate between the general population and specific patient groups. While some evidence, like that from Ayoub et al.Acute Pancreatitis With Recent Semaglutide Use (2025), suggests that GLP-1 RAs did not increase their risk of pancreatitis and might even be associated with a lower lifetime risk in some individuals, the context of use matters.We present the case of a 66-year-old woman who developed fatal necrotizingpancreatitissecondary tosemaglutide(Ozempic). This report emphasizes the ... Acute pancreatitis in non-diabetic patients using semaglutide for weight loss is uncommon but biologically possible, as stated by Ajmal et al.2025年5月19日—Althoughsemaglutide is safe for most people, it's important to know about potential side effects. One rare but serious risk is pancreatitis, ... (2025).Acute Pancreatitis Likely Due to Semaglutide - PMC - NIH Additionally, Ozempic may increase the risk of pancreatitis, especially for people with risk factors like diabetes, obesity, and gallstones. Identifying those at higher risk is therefore paramount.FATAL CASE OF SEVERE ACUTE NECROTIZING ... - Chest
For healthcare professionals, remaining vigilant for signs and symptoms of acute pancreatitis in patients receiving glucagon-like peptide-1 (GLP-1) receptor agonists, including semaglutide, is advised.作者:K Hughes·2024·被引用次数:9—Recent studies suggest that there isno increased risk of acute pancreatitiswith subcutaneous semaglutide use compared with non-users. Professionals should be alert to the risk of acute pancreatitis occurring after long-term semaglutide therapy, particularly in patients with multiple comorbidities. Similarly, those experiencing symptoms of pancreatitis should immediately consult their healthcare provider.2024年9月19日—Most case reports indicate acute pancreatitis as a side effectshortly after Semaglutide exposure. To our knowledge, no cases of acute ... As per information from Ozempic's official warnings, Ozempic may cause serious side effects, including: inflammation of your pancreas (pancreatitis), and patients are advised to stop using Ozempic and call their healthcare provider right away if this occurs.Reconciling GLP-1s and Pancreatitis - Consult QD
Recent data from various sources has indicated reports of acute pancreatitis following semaglutide use.作者:SC Lo Sr·2026—Here, we report a case ofacute pancreatitis occurring after long-term semaglutide therapyin a patient with multiple comorbidities, ... For example, in early 2025, there were reported cases of acute pancreatitis after taking semaglutide (Ozempic and Wegovy). While semaglutide is generally considered safe, awareness of potential risks like pancreatitis is crucial. Some studies have also found increased risks of gastrointestinal adverse events (biliary disease, pancreatitis, bowel obstruction, and gastroparesis) in users of GLP-1 receptor agonists.Acute Pancreatitis Likely Due to Semaglutide - PMC - NIH
In conclusion, the relationship between semaglutide and pancreatitis is a nuanced one. While large-scale studies and meta-analyses suggest no increased risk of acute pancreatitis with semaglutide use compared to placebo, individual case reports of semaglutide-induced pancreatitis, including severe forms like necrotizing pancreatitis, persistDecreased risk of recurrent acute pancreatitis with .... This underscores the importance of individualized risk assessment, careful patient selection, and heightened clinical awareness when prescribing semaglutide for diabetes management or weight loss. Patients should always discuss potential risks and benefits with their healthcare providers and report any concerning symptoms promptly.
Join the newsletter to receive news, updates, new products and freebies in your inbox.